Brian Coe
Chief Executive Officer
Belay Diagnostics, LLC
Chicago, IL
Brian Coe is CEO and co-founder of Belay Diagnostics, a liquid biopsy firm for CNS cancers. He is co-founder and chairman of MesoRNA, a sequencing platform for non-coding RNAs and their epitranscriptomic modifications. Mr. Coe also serves as adjunct professor of entrepreneurship at Chicago Booth. In 1995, Mr. Coe co-founded and served as CEO of Litholink Corporation, a CLIA laboratory for kidney stone patients that was acquired by LabCorp where he served as Senior Vice President. In 2012, Mr. Coe co-founded and served as the CEO of Talis Biomedical, a point-of-care molecular diagnostics platform that he led through its IPO.
The 30th Annual Executive War College will be held April 29-30, 2025, at the Hyatt Regency Hotel New Orleans.
Join our carefully selected line-up of clinical laboratory and pathology leaders, along with your peers, at Executive War College — the premier conference focusing on the best ideas, newest lab technologies, and most innovative management strategies now reshaping the clinical laboratory industry!
Stay up to date on the latest news about Executive War College, confirmed speakers and topics, and related Dark Report events. Subscribe now!
WHAT OUR ATTENDEES ARE SAYING
"Thank you for the Executive War College. This year was my first opportunity to attend and I was truly impressed with how well it was run, the quality of the speakers, and the accommodations. It is easy to see why attendance is growing every year."
